The gastric marginal zone B-cell lymphoma of MALT type

Blood

Volumn 96, Issue 2, 2000, Pages 410-419

  Zucca, Emanuele ^a,b   Bertoni, Francesco ^a   Roggero, Enrico ^a   Cavalli, Franco ^a  

^a ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^b OSPEDALE SAN GIOVANNI   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; RANITIDINE; TETRACYCLINE;

B CELL LYMPHOMA; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL FEATURE; GASTRITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HETEROZYGOSITY LOSS; IMMUNOPHENOTYPING; INFLAMMATION; KARYOTYPING; MOLECULAR GENETICS; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHODGKIN LYMPHOMA; PATHOGENESIS; PEYER PATCH; PRIORITY JOURNAL; REVIEW; STOMACH LYMPHOMA;

EID: 0034661539     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.2.410     Document Type: Review

References (141)

1. Isaacson PG, Spencer J. Malignant lymphoma of mucosa-associated lymphoid tissue. Histopathology. 1987;11:445-442.
2. Isaacson P. Gastric MALT lymphoma: from concept to cure. Ann Oncol. 1999;10:637-645.
3. Zucca E, Roggero E, Pileri S. B-cell lymphoma of MALT type: a review with special emphasis on diagnostic and management problems of low-grade gastric tumours. Br J Haematol. 1998;100: 3-14.
4. Pileri S, Piccaluga PP, De Vivo A, et al. Malignant lymphomas of the gastro-intestinal tract: a reappraisal on the basis of the newly proposed Revised European American Lymphoma Classification, Ital J Gastroenterol. 1994;26:405-418.
5. Isaacson PG. Pathogenesis and early lesions in extranodal lymphoma. Toxicol Lett. 1993;67:237-247.
6. Jonsson V, Wiik A, Hou-Jensen K, et al. Autoimmunity and extranodal lymphocytic infiltrates in lymphoproliferative disorders. J Intern Med. 1999; 245:277-286.
7. Zucca E, Bertoni F, Roggero E, et al. Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach. N Engl J Med. 1998;338:804-810.
8. Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, lsaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet. 1991;338:1175-1176.
9. Hyjek E, Isaacson PG. Primary B cell lymphoma of the thyroid and its relationship to Hashimoto's thyroiditis. Hum Pathol. 1988;19:1315-1326.
10. Hyjek E, Smith WJ, Isaacson PG. Primary B-cell lymphoma of salivary glands and its relationship to myoepithelial sialadenitis. Hum Pathol. 1988; 19:766-776.
11. Nakamura S, Aoyagi K, Furuse M, et al. B-cell monoclonality precedes the development of gastric MALT lymphoma in Helicobacter pylori-associated chronic gastritis. Am J Pathol. 1998;152: 1271-1279.
12. Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood. 1994;84:1361-1392.
13. Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the clinical advisory committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol. 1999;10:1419-1432.
14. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood. 1997;89:3909-3918.
15. Doglioni C, Wotherspoon AC, Moschini A, De Boni M, Isaacson PG. High incidence of primary gastric lymphoma in northeastern Italy. Lancet. 1992;339:834-835.
16. Zaki M, Schubert ML. Helicobacter pylori and gastric lymphoma. Gastroenterology. 1995;108: 610-612.
17. Cogliatti SB, Schmid U, Schumacher U, et al. Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterology. 1991; 101:1159-1170.
18. Radaszkiewicz T, Dragosics B, Bauer P. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. Gastroenterology. 1992;102:1628-1638.
19. Taal BG, Boot H, van Heerde P, de Jong D, Hart AA, Burgers JM. Primary non-Hodgkin lymphoma of the stomach: endoscopic pattern and prognosis in low versus high grade malignancy in relation to the MALT concept. Gut. 1996;39:556-561.
20. Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 1993;342:575-577.
21. Diss TC, Peng H, Wotherspoon AC, Isaacson PG, Pan L. Detection of monoclonality in low-grade B-cell lymphomas using the polymerase chain reaction is dependent on primer selection and lymphoma type. J Pathol. 1993;169:291-295.
22. Pan LX, Diss TC, Peng HZ, Isaacson PG. Clonality analysis of defined B-cell populations in archival tissue sections using microdissection and the polymerase chain reaction. Histopathology. 1994; 24:323-327.
23. Wotherspoon AC, Finn TM, Isaacson PG. Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue. Blood. 1995;85: 2000-2004.
24. Auer IA, Gascoyne RD, Connors JM, et al. t(11; 18)(q21;q21) is the most common translocation in MALT lymphomas. Ann Oncol. 1997;8:979-985.
25. Brynes RK, Almaguer PD, Leathery KE, et al. Numerical cytogenetic abnormalities of chromosomes 3, 7, and 12 in marginal zone B-cell lymphomas. Mod Pathol. 1996;9:995-1000.
26. Leroux D, Seite P, Hillion J, et al. t(11;18)(q21; q21) may delineate a spectrum of diffuse small B-cell lymphoma with extranodal involvement. Genes Chromosom Cancer. 1993;7:54-56.
27. Dierlamm J, Baens M, Wlodarska I, et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11; 18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood. 1999;93: 3601-3609.
28. Znang Q, Siebert R, Van M, et al. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1; 14)(p22;q32). Nat Genet. 1999;22:63-68.
29. Willis TG, Jadayel DM, Du MQ, et al. Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types. Cell. 1999;96:35-45.
30. Montalban C, Manzanal A, Castrillo JM, Escribano L, Bellas C. Low grade gastric B-cell MALT lymphoma progressing into high grade lymphoma: clonal identity of the two stages of the tumour, unusual bone involvement and leukemic dissemination. Histopathology. 1995;27:89-91.
31. Pinotti G, Zucca E, Roggero E, et al. Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leuk Lymphoma. 1997;26:527-537.
32. Hussell T, Isaacson PG, Crabtree JE, Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet. 1993;342: 571-574.
33. Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med. 1994;330:1267-1271.
34. Roggero E, Zucca E, Pinotti G, et al. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med. 1995;122:767-769.
35. Bayerdorffer E, Neubauer A, Rudolph B, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection: MALT Lymphoma Study Group. Lancet. 1995;345:1591-1594.
36. Qin Y, Greiner A, Trunk MJ, Schmausser B, Ott MM, Muller-Hermelink HK. Somatic hypermutation in low-grade mucosa-associated lymphoid tissue-type B-cell lymphoma. Blood. 1995;86: 3528-3534.
37. Du M, Diss TC, Xu C, Peng H, Isaacson PG, Pan L. Ongoing mutation in MALT lymphoma immunoglobulin gene suggests that antigen stimulation plays a role in the clonal expansion. Leukemia. 1996;10:1190-1197.
38. Bertoni F, Cazzaniga G, Bosshard G, et al. Immunoglobulin heavy chain diversity genes rearrangement pattern indicates that MALT-type gastric lymphoma B cells have undergone an antigen selection process. Br J Haematol. 1997;97:830-836.
39. Hussell T, Isaacson PG, Crabtree JE, Spencer J. Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. J Pathol. 1996;178:122-127.
40. Greiner A. Knorr C, Qin Y, et al. Low-grade B cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signaling and Th2-type cytokines for in vitro growth and differentiation. Am J Pathol. 1997;150:1583-1593.
41. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991;325:1127-1131.
42. Vineis P, Crosignani P, Sacerdote C, et al. Hematopoietic cancer and peptic ulcer: a multicenter case-control study. Carcinogenesis. 1999;20: 1459-1463.
43. Montalban C, Manzanal A, Boixeda D, et al. Helicobacter pylori eradication for the treatment of low-grade gastric MALT lymphoma: follow-up together with sequential molecular studies. Ann Oncol. 1997;8(suppl2):37-40.
44. Steinbach G, Ford R, Glober G, et al. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue: an uncontrolled trial. Ann Intern Med. 1999;131:88-95.
45. Ghia P, Nadler LM. Recent advances in lymphoma biology. Curr Opin Oncol. 1997;9:403-412.
46. Ott G, Katzenberger T, Greiner A, et al. The t(11; 18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT-) type. Cancer Res. 1997;57:3944-3948.
47. Akagi T, Tamura A, Motegi M, et al. Molecular cytogenetic delineation of the breakpoint at 18q21.1 in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Genes Chromosom Cancer. 1999;24:315-321.
48. Stoffel A, Rao PH, Louie DC, et al. Chromosome 18 breakpoint in t(11;18)(q21;q21) translocation associated with MALT lymphoma is proximal to BCL2 and distal to DCC. Genes Chromosomes Cancer. 1999;24:156-159.
49. Dyer MJ. Bcl10 mutations in malignancy. Br J Cancer. 1999;80:1491.
50. Fakruddin JM, Chaganti RS, Murty VV. Lack of BCL10 mutations in germ cell tumors and B cell lymphomas. Cell. 1999;97:683-684.
51. Luminari S, Infini D, Baldini L, et al. Analysis of BCL10 gene mutations in lymphoid malignancies. Leukemia. 2000;14:905-908.
52. Whang-Peng J, Knutsen T. Cytogenetics of non-Hodgkin's lymphomas. In: Magrath IT, ed. The Non-Hodgkin's Lymphomas. London, England: Arnold; 1997:277-307.
53. Ott G, Kalla J, Steinhoff A, et al. Trisomy 3 is not a common feature in malignant lymphomas of mucosa-associated lymphoid tissue type. Am J Pathol. 1998;153:689-694.
54. Hoeve MA, Gisbertz IA, Schouten HC, et al. Gastric low-grade MALT lymphoma, high-grade MALT lymphoma and diffuse large B cell lymphoma show different frequencies of trisomy. Leukemia. 1999;13:799-807.
55. Clark HM, Jones DB, Wright DH. Cytogenetic and molecular studies of t(14;18) and t(14;19) in nodal and extranodal B-cell lymphoma. J Pathol. 1992;166:129-137.
56. Wotherspoon AC, Pan LX, Diss TC, Isaacson PG. A genotypic study of low grade B-cell lymphomas, including lymphomas of mucosa associated lymphoid tissue (MALT). J Pathol. 1990;162:135-140.
57. Dierlamm J, Pittaluga S, Stul M, et al. BCL6 gene rearrangements also occur in marginal zone B-cell lymphoma. Br J Haematol. 1997;98:719-725.
58. Peng H, Diss T, Isaacson PG, Pan L. c-myc gene abnormalities in mucosa-associated lymphoid tissue (MALT) lymphomas. J Pathol. 1997;181: 381-386.
59. Cotter FE, Zucca E. Altered gene expression and oncogenesis of B-cell neoplasia. Ann Oncol. 1991;2:335-342.
60. Gamberi B, Gaidano G, Parsa N, et al. Microsatellite instability is rare in B-cell non-Hodgkin's lymphomas. Blood. 1997;89:975-979.
61. Peng H, Chen G, Du M, Singh N, Isaacson PG, Pan L. Replication error phenotype and p53 gene mutation in lymphomas of mucosa-associated lymphoid tissue. Am J Pathol. 1996;148:643-648.
62. Sol Mateo M, Mollejo M, Villuendas R, et al. Analysis of the frequency of microsatellite instability and p53 gene mutation in splenic marginal zone and MALT lymphomas. Mol Pathol. 1998; 51:262-267
63. Xu WS, Chan AC, Liang R, Srivastava G. No evidence of replication error phenotype in primary gastric lymphoma of mucosa-associated lymphoid tissue. Int J Cancer. 1998;76:635-638.
64. Furlan D, Bertoni F, Cerutti R, et al. Microsatellite instability in gastric MALT lymphomas and other associated neoplasms. Ann Oncol. 1999;10:783-788.
65. Hoeve MA, Ferreira Mota SC, Schuuring E, et al. Frequent allelic imbalance but infrequent microsatellite instability in gastric lymphoma. Leukemia. 1999;13:1804-1811.
66. Du M, Peng H, Singh N, Isaacson PG, Pan L. The accumulation of p53 abnormalities is associated with progression of mucosa-associated lymphoid tissue lymphoma. Blood. 1995;86:4587-4593.
67. Neumeister P, Hoefler G, Beham-Schmid C, et al. Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas. Gastroenterology. 1997; 112:1871-1875.
68. Martinez-Delgado B, Fernandez-Piqueras J, Garcia MJ, et al. Hypermethylation of a 5′CpG island of p16 is a frequent event in non-Hodgkin's lymphoma. Leukemia. 1997;11:425-428.
69. Gronbaek K, Straten PT, Ralfkiaer E, et al. Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity. Blood. 1998;92:3018-3024.
70. Bertoni F, Conconi A, Luminari S, et al. Lack of CD95/FAS gene somatic mutations in marginal zone B-cell lymphomas. Leukemia. 2000;3:446-448.
71. Zucca E, Bertoni F, Roggero E, et al. Autoreactive B cell clones in marginal-zone B cell lymphoma (MALT lymphoma) of the stomach [letter]. Leukemia. 1998;12:247-249.
72. Go MF. What are the host factors that place an individual at risk for Helicobacter pylori-associated disease? Gastroenterology. 1997;113(suppl 6):S15-S20.
73. Genta RM. The immunobiology of Helicobacter pylori gastritis. Semin Gastrointest Dis. 1997;8: 2-11.
74. Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science. 1999;284:1328-1333.
75. Eck M, Schmausser B, Haas R, Greiner A, Czub S, Muller-Hermelink HK. MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein. Gastroenterology. 1997;112:1482-1486.
76. Peng H, Ranaldi R, Diss TC, Isaacson PG, Bearzi I, Pan L. High frequency of CagA+ Helicobacter pylori infection in high-grade gastric MALT B-cell lymphomas. J Pathol. 1998;185:409-412.
77. de Jong D, van der Hulst RW, Pals G, et al. Gastric non-Hodgkin lymphomas of mucosa-associated lymphoid tissue are not associated with more aggressive Helicobacter pylori strains as identified by CagA. Am J Clin Pathol. 1996;106: 670-675.
78. van Doorn NE, Namavar F, van Doorn LJ, Durrani Z, Kuipers EJ, Vandenbroucke-Grauls CM, Analysis of vacA, cagA, and IS605 genotypes and those determined by PCR amplification of DNA between repetitive sequences of Helicobacter pylori strains isolated from patients with nonulcer dyspepsia or mucosa-associated lymphoid tissue lymphoma. J Clin Microbiol. 1999;37:2348-2349.
79. Taupin A, Occhialini A, Ruskone-Fourmestraux A, Delchier JC, Rambaud JC, Megraud F. Serum antibody responses to helicobacter pylori and the cagA marker in patients with mucosa-associated lymphoid tissue lymphoma. Clin Diagn Lab Immunol. 1999;6:633-638.
80. Lamarque D, Gilbert T, Roudot-Thoraval F, Deforges L, Chaumette MT, Delchier JC. Seroprevalence of eight Helicobacter pylori antigens among 182 patients with peptic ulcer, MALT gastric lymphoma or non-ulcer dyspepsia. Higher rate of seroreactivity against CagA and 35-kDa antigens in patients with peptic ulcer originating from Europe and Africa. Eur J Gastroenterol Hepatol. 1999;11: 721-726.
81. Chang CS, Chen LT, Yang JC, Lin JT, Chang KC, Wang JT. Isolation of a Helicobacter pylori protein, FldA, associated with mucosa-associated lymphoid tissue lymphoma of the stomach. Gastroenterology. 1999;117:82-88.
82. Kawahara Y, Yokota K, Mizuno M, et al. Antibodies to human gastric epithelial cells and heat shock protein 60 in helicobacter pylori positive mucosa associated lymphoid tissue lymphoma. Gut. 1999;45:20-23.
83. Kobayashi K, Yokota K, Yoshino T, et al. Detection of Helicobacter pylori associated antigen and heat shock protein 60 on follicular dendritic cells in the germinal centres of low grade B cell lymphoma of gastric mucosa associated lymphoid tissue (MALT). J Clin Pathol. 1998;51:396-398.
84. Oberhuber G, Kranz A, Dejaco C, et al. Blood groups Lewis(b) and ABH expression in gastric mucosa: lack of inter-relation with Helicobacter pylori colonisation and occurrence of gastric MALT lymphoma. Gut. 1997;41:37-42.
85. Luppi M, Longo G, Ferrari MG, et al. Additional neoplasms and HCV infection in low-grade lymphoma of MALT type. Br J Haematol. 1996;94: 373-375.
86. Trepo C, Berthillon P, Vitvitski L. HCV and lymphoproliferative diseases. Ann Oncol. 1998;9: 469-470.
87. Zucca E, Roggero E, Maggi-Solca N, et al. Prevalence of Helicobacter pylori and hepatitis C virus (HCV) infections among non-Hodgkin's lymphoma patients in southern Switzerland. Haematologica. 2000;85:147-153.
88. Isaacson PG, Norton AJ. Malignant lymphoma of the gastrointestinal tract. In: Isaacson PG, Norton AJ, eds. Extranodal Lymphomas. Edinburgh, Scotland: Churchill Livingstone; 1994:15-65.
89. Chan JK. Gastrointestinal lymphomas: an overview with emphasis on new findings and diagnostic problems. Semin Diagn Pathol. 1996;13:260-296.
90. Isaacson PG, Wotherspoon AC, Diss T, Pan LX. Follicular colonization in B-cell lymphoma of mucosa-associated lymphoid tissue. Am J Surg Pathol. 1991;15:819-828.
91. de Jong D, Aleman BM, Taal BG, Boot H. Controversies and consensus in the diagnosis, work-up and treatment of gastric lymphoma: an international survey. Ann Oncol. 1999;10:275-280.
92. Kurtin PJ. How do you distinguish benign from malignant extranodal small B-cell proliferations? Am J Clin Pathol. 1999;111:S119-S125.
93. Harris NL, Isaacson PG. What are the criteria for distinguishing MALT from non-MALT lymphoma at extranodal sites? Am J Clin Pathol. 1999;111: S126-S132.
94. Burke JS. Are there site-specific differences among the MALT lymphomas-morphologic, clinical? Am J Clin Pathol. 1999;111:S133-S143.
95. Bertoni F, Cotter F, Zucca E. Molecular genetics of extranodal marginal zone (MALT-type) B-cell lymphoma. Leuk Lymphoma. 1999;35:57-68.
96. de Mascarel A, Dubus P, Belleannee G, Megraud F, Merlio JP. Low prevalence of monoclonal B cells in Helicobacter pylori gastritis patients with duodenal ulcer. Hum Pathol. 1998;29:784-790.
97. Aiello A, Giardini R, Tondini C. PCR-based clonality analysis: a reliable method for the diagnosis and follow-up monitoring of conservatively treated gastric B-cell MALT lymphomas? Histopathology. 1999;34:326-330.
98. Diss TC, Pan L. Polymerase chain reaction in the assessment of lymphomas. Cancer Surv. 1997; 30:21-44.
99. Wotherspoon AC, Doglioni C, Isaacson PG. Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue (MALT): a multifocal disease. Histopathology. 1992;20:29-34.
100. Du MQ, Xu CF, Diss TC, et al. Intestinal dissemination of gastric mucosa-associated lymphoid tissue lymphoma. Blood. 1996;88:4445-4451.
101. Drillenburg P, van der Voort R, Koopman G, et al. Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas. Am J Pathol. 1997; 150:919-927.
102. Isaacson PG, Spencer J. The biology of low grade MALT lymphoma. J Clin Pathol. 1995;48: 395-397.
103. Montalban C, Castrillo JM, Abraira V, et al. Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma: clinicopathological study and evaluation of the prognostic factors in 143 patients. Ann Oncol. 1995;6:355-362.
104. Morton JE, Leyland MJ, Vaughan Hudson G, et al. Primary gastrointestinal non-Hodgkin's lymphoma: a review of 175 British National Lymphoma Investigation cases. Br J Cancer. 1993; 67:776-782
105. Chan JK, Ng CS, Isaacson PG. Relationship between high-grade lymphoma and low-grade B-cell mucosa-associated lymphoid tissue lymphoma (MALToma) of the stomach. Am J Pathol. 1990;136:1153-1164.
106. de Jong D, Boot H, van Heerde P, Hart GA, Taal BG. Histological grading in gastric lymphoma: pretreatment criteria and clinical relevance. Gastroenterology. 1997;112:1466-1474.
107. McCormick C, Philp E, Mansi J, Livni N, McCarthy K. Clonal analysis of three morphologically distinct lymphomas occurring in the same patient. J Clin Pathol. 1994;47:1038-1042.
108. Rosenwald A, Ott G, Stilgenbauer S, et al. Exclusive detection of the t(11;18)(q21;q21) in extranodal marginal zone B cell lymphomas (MZBL) of MALT type in contrast to other MZBL and extranodal large B cell lymphomas. Am J Pathol. 1999; 155:1817-1821.
109. Castrillo JM, Montalban C, Obeso G, Piris MA, Rivas MC. Gastric B-cell mucosa associated lymphoid tissue lymphoma: a clinicopathological study in 56 patients. Gut. 1992;33:1307-1311.
110. Thieblemont C, Bastion Y, Berger F, et al. Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol. 1997;15: 1624-1630.
111. Pileri SA, Sabattini E. A rational approach to immunohistochemical analysis of malignant lymphomas on paraffin wax sections. J Clin Pathol. 1997;50:2-4.
112. Koulis A, Diss T, Isaacson PG, Dogan A. Characterization of tumor-infiltrating T lymphocytes in B-cell lymphomas of mucosa-associated lymphoid tissue. Am J Pathol. 1997;151:1353-1360.
113. RohatinerA, d'Amore F, Coiffier B, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol. 1994;5:397-400.
114. Cutler AF, Havstad S, Ma CK, Blaser MJ, Perez-Perez GI, Schubert TT. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection. Gastroenterology. 1995;109:136-141.
115. Fisher RI, Dahlberg S, Nathwani BN, Banks PM, Miller TP, Grogan TM. A clinical analysis of two indolent lymphoma entities: mantle cell lymphoma and marginal zone lymphoma (including the mucosa-associated lymphoid tissue and monocytoid B-cell subcategories): a Southwest Oncology Group study. Blood. 1995;85:1075-1082.
116. Eidt S, Stolte M, Fischer R. Factors influencing lymph node infiltration in primary gastric malignant lymphoma of the mucosa-associated lymphoid tissue. Pathol Res Pract. 1994;190:1077-1081.
117. Pavlick AC, Gerdes H, Portlock CS. Endoscopic ultrasound in the evaluation of gastric small lymphocytic mucosa-associated lymphoid tumors. J Clin Oncol. 1997;15:1761-1766.
118. Sackmann M, Morgner A, Rudolph B, et al. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging: MALT Lymphoma Study Group. Gastroenterology. 1997;113:1087-1090.
119. E low-grade B-cell mucosa-associated lymphoid tissue type following Helicobacter pylori eradication treatment. Int J Oncol. 1999;15:899-907.
120. Savio A, Franzin G, Wotherspoon AC, et al. Diagnosis and posttreatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: histology, polymerase chain reaction, or both? Blood. 1996;87:1255-1260.
121. Nobre-Leitao C, Lage P, Cravo M, et al. Treatment of gastric MALT lymphoma by Helicobacter pylori eradication: a study controlled by endoscopic ultrasonography. Am J Gastroenterol. 1998;93:732-736.
122. Zucca E, Pinotti G, Roggero E, et al. High incidence of other neoplasms in patients with low-grade gastric MALT lymphoma. Ann Oncol. 1995; 6:726-728.
123. Montalban C, Castrillo JM, Lopez-Abente G, et al. Other cancers in patients with gastric MALT lymphoma. Leuk Lymphoma. 1999;33:161-168.
124. Au WY, Gascoyne RD, Le N, et al. Incidence of second neoplasms in patients with MALT lymphoma: no increase in risk above the background population. Ann Oncol. 1999;10:317-321.
125. Neubauer A, Thiede C, Morgner A, et al. Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst. 1997;89:1350-1355.
126. Zucca E, Roggero E, Traulle C, et al. Early interim report of the LY03 randomised cooperative trial of observation vs chlorambucil after anti-Helicobacter therapy in low-grade gastric lymphoma [abstract]. Ann Oncol. 1999;10(suppl 3):25.
127. Zucca E, Bertoni F, Roggero E, Gisi M, Cavalli F. Patient-specific molecular monitoring of MALT-lymphoma after antibiotic treatment [abstract]. Proc Am Soc Clin Oncol. 1999;18:10a.
128. Press O. Non-Hodgkin's lymphoma. In: Johnson D, Whippen D, eds. American Society of Clinical Oncology: 35th Annual Meeting Summaries. Baltimore, MD: Lippincott Williams & Wilkins; 1999: 79-82.
129. Roggero E, Zucca E, Cavalli F. Gastric mucosa-associated lymphoid tissue lymphomas: more than a fascinating model. J Natl Cancer Inst 1997;89:1328-1330.
130. Zucca E, Cavalli F. Gut lymphomas. Baillieres Clin Haematol. 1996;9:724-741.
131. Hunt RH. Peptic ulcer disease: defining the treatment strategies in the era of Helicobacter pylori. Am J Gastroenterol. 1997;92:536-340.
132. Malfertheiner P, Megraud F, O'Morain C, et al. Current European concepts in the management of Helicobacter pylori infection - the Maastricht Consensus Report: The European Helicobacter Pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol. 1997;9:1-2.
133. Richards MA, Gregory WM, Hall P, et al. Management of localized non-Hodgkin's lymphoma: the experience at St. Bartholomew's Hospital 1972-1985. Hematol Oncol. 1989;7:1-18.
134. Hammel P, Haloun C, Chaumette MT, et al. Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression. J Clin Oncol. 1995;13:2524-2529.
135. Fung CY, Grossbard ML, Linggood RM, et al. Mucosa-associated lymphoid tissue lymphoma of the stomach: long term outcome after local treatment. Cancer. 1999;85:9-17.
136. Schechter NR, Portlock CS, Yahalom J. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol. 1998;16:1916-1921.
137. Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin's lymphomas Part 1: gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol. 1997;8:727-737.
138. Coiffier B, Salles G. Does surgery belong to medical history for gastric lymphomas? Ann Oncol. 1997;8:419-421.
139. Seymour JF, Anderson RP, Bhathal PS. Regression of gastric lymphoma with therapy for Helicobacter pylori infection [letter]. Ann Intern Med. 1997;127:247.
140. Roggero E, Copie-Bergman C, Traullé C, et al. regression of high grade B-cell gastric lymphoma after eradication of Helicobacter pylori infection [abstract]. Ann Oncol. 1999;10(suppl 3):67.
141. Boot H, de Jong D, van Heerde P, Taal B. Role of Helicobacter pylori eradication in high-grade MALT lymphoma [letter]. Lancet. 1995;346:448.